UNH — UnitedHealth Group Incorporated stock price, charts and financials
QT64UnitedHealth Group IncorporatedUnitedHealth Group Incorporated (NYSE: UNH) is a Healthcare company in the Medical - Healthcare Plans industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | S&P 500, DJIA | P/E | 25.28 | EPS (ttm) | 15.55 | Insider Own | 0.19% | Shs Outstand | 908.14M | Perf Week | -0.82% |
| Market Cap | 356.96B | Forward P/E | 17.51 | EPS next Y | 22.45 | Insider Trans | -0.14% | Shs Float | 906.11M | Perf Month | -3.84% |
| Enterprise Value | 398.82B | PEG | 1.71 | EPS next Q | 4.09 | Inst Own | 88.20% | Short Float | 1.71% | Perf Quarter | -4.83% |
| Income | 14.12B | P/S | 0.79 | EPS this Y | 27.07% | Inst Trans | 0.00% | Short Ratio | 2.56 | Perf Half Y | 39.22% |
| Sales | 450.13B | P/B | 3.37 | EPS next Y | 13.60% | ROA | 4.56% | Short Interest | 15.46M | Perf YTD | 19.07% |
| Book/sh | 116.67 | P/C | 11.34 | EPS next 5Y | 14.77% | ROE | 14.40% | 52W High | 461.61 -14.85% | Perf Year | 22.74% |
| Cash/sh | 34.65 | P/FCF | 15.27 | EPS past 3/5Y | -14.52% -3.77% | ROIC | 6.84% | 52W Low | 255.97 53.56% | Perf 3Y | -17.47% |
| Dividend Est. | 9.28 (2.36%) | EV/EBITDA | 15.48 | Sales past 3/5Y | 11.35% 11.72% | Gross Margin | 22.49% | Volatility | 3.17% 2.18% | Perf 5Y | -5.58% |
| Dividend TTM | 8.95 (2.28%) | EV/Sales | 0.89 | EPS Y/Y TTM | 0.26% | Oper. Margin | 4.82% | ATR (14) | 10.38 | Perf 10Y | 186.34% |
| Dividend Ex-Date | Sep 14, 2026 | Quick Ratio | 1.24 | Sales Y/Y TTM | 12.45% | Profit Margin | 3.14% | RSI (14) | 44.02 | Recom | 2.21 |
| Dividend Gr. 3/5Y | 10.90% 12.57% | Current Ratio | 1.24 | EPS Q/Q | 56.37% | SMA20 | -0.76% | Beta | 0.60 | Target Price | 473.89 |
| Payout | 57.33% | Debt/Eq | 0.77 | Sales Q/Q | 0.37% | SMA50 | -4.29% | Rel Volume | 1.44 | Prev Close | 400.84 |
| Employees | 390,000 | LT Debt/Eq | 0.71 | Earnings | Oct 27 | SMA200 | 11.55% | Avg Volume | 5.34M | Price | 393.06 |
| IPO Date | Oct 17, 1984 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 30.01% 1.11% | Net Debt/EBITDA | 1.74 | Volume | 7,707,112 | Change | -1.94% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-21-26 | Reiterated | BMO Capital | Market Perform | $512 |
| Jul-21-26 | Reiterated | D.A. Davidson | $512 | |
| Jul-20-26 | Reiterated | Wells Fargo | Overweight | $485 → $526 |
| Jul-20-26 | Reiterated | Barclays | Overweight | $429 → $441 |
| Jul-17-26 | Reiterated | Truist Securities | Buy | $480 → $500 |
| Jul-17-26 | Reiterated | UBS | Buy | $460 → $490 |
| Jul-17-26 | Reiterated | Morgan Stanley | Overweight | $468 → $529 |
| Jul-17-26 | Reiterated | Keybanc | Overweight | $475 → $500 |
| Jul-16-26 | Reiterated | Robert W. Baird | $198 → $453 | |
| Jul-16-26 | Reiterated | Piper Sandler | Overweight | $475 → $477 |
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 450,129 | 447,567 | 400,278 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 348,915 | 364,650 | 310,879 | — | — | — | — | — | — | |
| Gross Profit | 101,214 | 82,917 | 89,399 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 15,390 | 0 | 0 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 64,148 | 63,953 | 57,112 | — | — | — | — | — | — | |
| Operating Income | 21,676 | 18,964 | 32,287 | — | — | — | — | — | — | |
| Interest Expense | 3,894 | 4,002 | 3,906 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -342 | -265 | -8,310 | — | — | — | — | — | — | |
| Net Income Before Taxes | 17,440 | 14,697 | 20,071 | — | — | — | — | — | — | |
| Income Taxes | 2,528 | 1,890 | 4,829 | — | — | — | — | — | — | |
| Consolidated Net Income | 14,122 | 12,056 | 14,405 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 14,912 | 12,807 | 15,242 | — | — | — | — | — | — | |
| Net Income | 14,122 | 12,056 | 14,405 | — | — | — | — | — | — | |
| EPS (Recurring) | 15.55 | 13.23 | 15.64 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 15.55 | 13.23 | 15.64 | — | — | — | — | — | — | |
| EPS (Diluted) | 15.55 | 13.23 | 15.51 | — | — | — | — | — | — | |
| EBITDA | 25,763 | 23,060 | 28,076 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 25.28 | 24.95 | 32.62 | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.79 | 0.67 | 1.17 | — | — | — | — | — | — | |
| Gross Margin | 22.49 | 18.53 | 22.33 | — | — | — | — | — | — | |
| Operating Margin | 4.82 | 4.24 | 8.07 | — | — | — | — | — | — | |
| Net Margin | 3.14 | 2.69 | 3.60 | — | — | — | — | — | — | |
| Shares Outstanding | 906 | 910 | 929 | — | — | — | — | — | — | |
| Market Capitalization | 356,112 | 300,400 | 469,944 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Conway Patrick Hugh | Chief Executive Officer, Optum | Aug 21 '26 | Sale | 390.00 | 1,169 | 455,910 | 15,328 | Aug 25 |
| Conway Patrick Hugh | Chief Executive Officer, Optum | Aug 05 '26 | Sale | 410.00 | 500 | 205,000 | 16,497 | Aug 07 |
| Conway Patrick Hugh | Chief Executive Officer, Optum | Apr 23 '26 | Sale | 355.00 | 800 | 284,000 | 17,805 | Apr 27 |
| Baker Charles D. | Director | Sep 11 '25 | Sale | 356.05 | 27 | 9,613 | 0 | Sep 15 |
| Conway Patrick Hugh | Chief Executive Officer, Optum | Jun 10 '25 | Sale | 305.00 | 589 | 179,645 | 10,398 | Jun 12 |
| HEMSLEY STEPHEN J | CEO, UHG | May 16 '25 | Buy | 288.57 | 86,700 | 25,019,019 | 679,493 | May 16 |
| REX JOHN F | President & CFO | May 16 '25 | Buy | 291.12 | 17,175 | 4,999,919 | 203,796 | May 16 |
| Gil Kristen | Director | May 15 '25 | Buy | 271.17 | 3,700 | 1,003,329 | 3,818 | May 16 |
| Noseworthy John H | Director | May 14 '25 | Buy | 312.16 | 300 | 93,647 | 6,063 | May 16 |
| FLYNN TIMOTHY PATRICK | Director | May 14 '25 | Buy | 320.80 | 1,533 | 491,786 | 6,033 | May 16 |
| REX JOHN F | President & CFO | Feb 07 '25 | Option Exercise | 108.97 | 25,504 | 2,779,171 | 191,691 | Feb 07 |
| FLYNN TIMOTHY PATRICK | Director | Jan 17 '25 | Buy | 511.57 | 1,000 | 511,575 | 4,500 | Jan 22 |
| McSweeney Erin | EVP & Chief People Officer | Nov 11 '24 | Sale | 626.23 | 701 | 438,987 | 7,105 | Nov 13 |